Epigenetic remodeling to improve the efficacy of immunotherapy in human glioblastoma: pre-clinical evidence for development of new immunotherapy approaches.
Lofiego MF, Piazzini F, Caruso FP, Marzani F, Solmonese L, Bello E, Celesti F, Costa MC, Noviello T, Mortarini R, Anichini A, Ceccarelli M, Coral S, Di Giacomo AM, Maio M, Covre A; EPigenetic Immune-oncology Consortium Airc (EPICA) investigators.
Lofiego MF, et al. Among authors: costa mc.
J Transl Med. 2024 Mar 1;22(1):223. doi: 10.1186/s12967-024-05040-x.
J Transl Med. 2024.
PMID: 38429759
Free PMC article.